Evidence map›Paper›PMID 42080164›Full record

ArticleRSC advances2026

Cooperative supramolecular integration of QS-21 into polymeric micelles as a tunable nanoadjuvant platform for subunit vaccines.

Patricio Guillermo Márquez, Leonardo Gabriel Alonso, Juan Ignacio Marfía, Ignacio Smith, Ana Carolina Mourelle, María Lina Formica, María Victoria Miranda, Silvina Noemí Valdez, Federico Javier Wolman, Romina Julieta Glisoni

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patricio Guillermo MárquezUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0009-0003-1771-4640
Leonardo Gabriel AlonsoUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0000-0002-0596-703X
Juan Ignacio MarfíaUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0009-0000-0571-5521
Ignacio SmithUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0000-0003-0676-9999
Ana Carolina MourelleUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0009-0004-6712-5980
María Lina FormicaUnidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba Ciudad Universitaria Córdoba 5000 Argentina.ORCID https://orcid.org/0000-0001-7225-0998
María Victoria MirandaUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0000-0003-0862-2122
Silvina Noemí ValdezUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0000-0003-1714-1005
Federico Javier WolmanUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0000-0002-6869-7145
Romina Julieta GlisoniUniversidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología Junín 956 C1113AAD Buenos Aires Argentina.ORCID https://orcid.org/0000-0002-7845-1800

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potent saponin adjuvants such as QS-21, used in clinically approved vaccine formulations, remain limited by intrinsic hemolytic activity and restricted aqueous stability, motivating biomaterials strategies aimed at regulating their interfacial behavior while preserving immunostimulatory function. Here, we show that when combined with amphiphilic PEO-PPO triblock copolymers (P123 and F127), QS-21 appears to participate in cooperative supramolecular integration into polymeric micelles rather than behaving as a passively encapsulated cargo. This architecture-dependent organization gives rise to structurally coherent nanosystems with enhanced dilution stability and controlled membrane activity. Comparative analysis revealed that P123/QS-21 assemblies form compact, monodisperse micelles (∼21 nm) with marked resistance to dilution, whereas F127-based systems display greater structural heterogeneity and reduced supramolecular robustness. Cooperative integration is associated with attenuation of hemolytic activity in a concentration-dependent manner relative to free QS-21 while preserving functional accessibility, consistent with controlled interfacial presentation of the saponin. These physicochemical features are supported by DLS, TEM, and NTA analyses.

Identifiers

PMID42080164
PMCPMC13133659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.